Global Exosome Proteomics Service Market Research Report 2023

Publication ID:

PB504233661

Publication Date:

June 2, 2023

Pages:

110

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global Exosome Proteomics Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Exosome Proteomics Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Exosome Proteomics Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Exosome Proteomics Service in Biomarker Discovery is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Exosome Proteomics Service include System Biosciences, HansaBioMed Life Sciences Ltd., QIAGEN Inc., Norgen Biotek Corp., Bio-Techne, AMSBIO LLC, NX Pharmagen, Thermo Fisher Scientific and Sistemic Ltd., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Exosome Proteomics Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Proteomics Service.
The Exosome Proteomics Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Exosome Proteomics Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Proteomics Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
System Biosciences
HansaBioMed Life Sciences Ltd.
QIAGEN Inc.
Norgen Biotek Corp.
Bio-Techne
AMSBIO LLC
NX Pharmagen
Thermo Fisher Scientific
Sistemic Ltd.
Exosome Diagnostics
Lonza Group Ltd.
Evox Therapeutics Ltd.
Evomic Science LLC
ExoCyte Therapeutics LLC
Optofluidics, Inc.
New England Biolabs
Izon Science Ltd.
Miltenyi Biotec GmbH
Codiak BioSciences
Ology Bioservices Inc.
Segment by Type
Separate
Identification and Characterization
Quantitative Analysis
Content Analysis
Functional Analysis
Segment by Application
Biomarker Discovery
Drug Delivery
Disease Diagnosis and Monitoring
Personalized Medicine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Proteomics Service companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Proteomics Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Separate
1.2.3 Identification and Characterization
1.2.4 Quantitative Analysis
1.2.5 Content Analysis
1.2.6 Functional Analysis
1.3 Market by Application
1.3.1 Global Exosome Proteomics Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biomarker Discovery
1.3.3 Drug Delivery
1.3.4 Disease Diagnosis and Monitoring
1.3.5 Personalized Medicine
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Proteomics Service Market Perspective (2018-2029)
2.2 Exosome Proteomics Service Growth Trends by Region
2.2.1 Global Exosome Proteomics Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Exosome Proteomics Service Historic Market Size by Region (2018-2023)
2.2.3 Exosome Proteomics Service Forecasted Market Size by Region (2024-2029)
2.3 Exosome Proteomics Service Market Dynamics
2.3.1 Exosome Proteomics Service Industry Trends
2.3.2 Exosome Proteomics Service Market Drivers
2.3.3 Exosome Proteomics Service Market Challenges
2.3.4 Exosome Proteomics Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Proteomics Service Players by Revenue
3.1.1 Global Top Exosome Proteomics Service Players by Revenue (2018-2023)
3.1.2 Global Exosome Proteomics Service Revenue Market Share by Players (2018-2023)
3.2 Global Exosome Proteomics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Exosome Proteomics Service Revenue
3.4 Global Exosome Proteomics Service Market Concentration Ratio
3.4.1 Global Exosome Proteomics Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Proteomics Service Revenue in 2022
3.5 Exosome Proteomics Service Key Players Head office and Area Served
3.6 Key Players Exosome Proteomics Service Product Solution and Service
3.7 Date of Enter into Exosome Proteomics Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Proteomics Service Breakdown Data by Type
4.1 Global Exosome Proteomics Service Historic Market Size by Type (2018-2023)
4.2 Global Exosome Proteomics Service Forecasted Market Size by Type (2024-2029)
5 Exosome Proteomics Service Breakdown Data by Application
5.1 Global Exosome Proteomics Service Historic Market Size by Application (2018-2023)
5.2 Global Exosome Proteomics Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Exosome Proteomics Service Market Size (2018-2029)
6.2 North America Exosome Proteomics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Exosome Proteomics Service Market Size by Country (2018-2023)
6.4 North America Exosome Proteomics Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Proteomics Service Market Size (2018-2029)
7.2 Europe Exosome Proteomics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Exosome Proteomics Service Market Size by Country (2018-2023)
7.4 Europe Exosome Proteomics Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Proteomics Service Market Size (2018-2029)
8.2 Asia-Pacific Exosome Proteomics Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Exosome Proteomics Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Exosome Proteomics Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Proteomics Service Market Size (2018-2029)
9.2 Latin America Exosome Proteomics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Exosome Proteomics Service Market Size by Country (2018-2023)
9.4 Latin America Exosome Proteomics Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Proteomics Service Market Size (2018-2029)
10.2 Middle East & Africa Exosome Proteomics Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Exosome Proteomics Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Exosome Proteomics Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 System Biosciences
11.1.1 System Biosciences Company Detail
11.1.2 System Biosciences Business Overview
11.1.3 System Biosciences Exosome Proteomics Service Introduction
11.1.4 System Biosciences Revenue in Exosome Proteomics Service Business (2018-2023)
11.1.5 System Biosciences Recent Development
11.2 HansaBioMed Life Sciences Ltd.
11.2.1 HansaBioMed Life Sciences Ltd. Company Detail
11.2.2 HansaBioMed Life Sciences Ltd. Business Overview
11.2.3 HansaBioMed Life Sciences Ltd. Exosome Proteomics Service Introduction
11.2.4 HansaBioMed Life Sciences Ltd. Revenue in Exosome Proteomics Service Business (2018-2023)
11.2.5 HansaBioMed Life Sciences Ltd. Recent Development
11.3 QIAGEN Inc.
11.3.1 QIAGEN Inc. Company Detail
11.3.2 QIAGEN Inc. Business Overview
11.3.3 QIAGEN Inc. Exosome Proteomics Service Introduction
11.3.4 QIAGEN Inc. Revenue in Exosome Proteomics Service Business (2018-2023)
11.3.5 QIAGEN Inc. Recent Development
11.4 Norgen Biotek Corp.
11.4.1 Norgen Biotek Corp. Company Detail
11.4.2 Norgen Biotek Corp. Business Overview
11.4.3 Norgen Biotek Corp. Exosome Proteomics Service Introduction
11.4.4 Norgen Biotek Corp. Revenue in Exosome Proteomics Service Business (2018-2023)
11.4.5 Norgen Biotek Corp. Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Detail
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne Exosome Proteomics Service Introduction
11.5.4 Bio-Techne Revenue in Exosome Proteomics Service Business (2018-2023)
11.5.5 Bio-Techne Recent Development
11.6 AMSBIO LLC
11.6.1 AMSBIO LLC Company Detail
11.6.2 AMSBIO LLC Business Overview
11.6.3 AMSBIO LLC Exosome Proteomics Service Introduction
11.6.4 AMSBIO LLC Revenue in Exosome Proteomics Service Business (2018-2023)
11.6.5 AMSBIO LLC Recent Development
11.7 NX Pharmagen
11.7.1 NX Pharmagen Company Detail
11.7.2 NX Pharmagen Business Overview
11.7.3 NX Pharmagen Exosome Proteomics Service Introduction
11.7.4 NX Pharmagen Revenue in Exosome Proteomics Service Business (2018-2023)
11.7.5 NX Pharmagen Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Exosome Proteomics Service Introduction
11.8.4 Thermo Fisher Scientific Revenue in Exosome Proteomics Service Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Sistemic Ltd.
11.9.1 Sistemic Ltd. Company Detail
11.9.2 Sistemic Ltd. Business Overview
11.9.3 Sistemic Ltd. Exosome Proteomics Service Introduction
11.9.4 Sistemic Ltd. Revenue in Exosome Proteomics Service Business (2018-2023)
11.9.5 Sistemic Ltd. Recent Development
11.10 Exosome Diagnostics
11.10.1 Exosome Diagnostics Company Detail
11.10.2 Exosome Diagnostics Business Overview
11.10.3 Exosome Diagnostics Exosome Proteomics Service Introduction
11.10.4 Exosome Diagnostics Revenue in Exosome Proteomics Service Business (2018-2023)
11.10.5 Exosome Diagnostics Recent Development
11.11 Lonza Group Ltd.
11.11.1 Lonza Group Ltd. Company Detail
11.11.2 Lonza Group Ltd. Business Overview
11.11.3 Lonza Group Ltd. Exosome Proteomics Service Introduction
11.11.4 Lonza Group Ltd. Revenue in Exosome Proteomics Service Business (2018-2023)
11.11.5 Lonza Group Ltd. Recent Development
11.12 Evox Therapeutics Ltd.
11.12.1 Evox Therapeutics Ltd. Company Detail
11.12.2 Evox Therapeutics Ltd. Business Overview
11.12.3 Evox Therapeutics Ltd. Exosome Proteomics Service Introduction
11.12.4 Evox Therapeutics Ltd. Revenue in Exosome Proteomics Service Business (2018-2023)
11.12.5 Evox Therapeutics Ltd. Recent Development
11.13 Evomic Science LLC
11.13.1 Evomic Science LLC Company Detail
11.13.2 Evomic Science LLC Business Overview
11.13.3 Evomic Science LLC Exosome Proteomics Service Introduction
11.13.4 Evomic Science LLC Revenue in Exosome Proteomics Service Business (2018-2023)
11.13.5 Evomic Science LLC Recent Development
11.14 ExoCyte Therapeutics LLC
11.14.1 ExoCyte Therapeutics LLC Company Detail
11.14.2 ExoCyte Therapeutics LLC Business Overview
11.14.3 ExoCyte Therapeutics LLC Exosome Proteomics Service Introduction
11.14.4 ExoCyte Therapeutics LLC Revenue in Exosome Proteomics Service Business (2018-2023)
11.14.5 ExoCyte Therapeutics LLC Recent Development
11.15 Optofluidics, Inc.
11.15.1 Optofluidics, Inc. Company Detail
11.15.2 Optofluidics, Inc. Business Overview
11.15.3 Optofluidics, Inc. Exosome Proteomics Service Introduction
11.15.4 Optofluidics, Inc. Revenue in Exosome Proteomics Service Business (2018-2023)
11.15.5 Optofluidics, Inc. Recent Development
11.16 New England Biolabs
11.16.1 New England Biolabs Company Detail
11.16.2 New England Biolabs Business Overview
11.16.3 New England Biolabs Exosome Proteomics Service Introduction
11.16.4 New England Biolabs Revenue in Exosome Proteomics Service Business (2018-2023)
11.16.5 New England Biolabs Recent Development
11.17 Izon Science Ltd.
11.17.1 Izon Science Ltd. Company Detail
11.17.2 Izon Science Ltd. Business Overview
11.17.3 Izon Science Ltd. Exosome Proteomics Service Introduction
11.17.4 Izon Science Ltd. Revenue in Exosome Proteomics Service Business (2018-2023)
11.17.5 Izon Science Ltd. Recent Development
11.18 Miltenyi Biotec GmbH
11.18.1 Miltenyi Biotec GmbH Company Detail
11.18.2 Miltenyi Biotec GmbH Business Overview
11.18.3 Miltenyi Biotec GmbH Exosome Proteomics Service Introduction
11.18.4 Miltenyi Biotec GmbH Revenue in Exosome Proteomics Service Business (2018-2023)
11.18.5 Miltenyi Biotec GmbH Recent Development
11.19 Codiak BioSciences
11.19.1 Codiak BioSciences Company Detail
11.19.2 Codiak BioSciences Business Overview
11.19.3 Codiak BioSciences Exosome Proteomics Service Introduction
11.19.4 Codiak BioSciences Revenue in Exosome Proteomics Service Business (2018-2023)
11.19.5 Codiak BioSciences Recent Development
11.20 Ology Bioservices Inc.
11.20.1 Ology Bioservices Inc. Company Detail
11.20.2 Ology Bioservices Inc. Business Overview
11.20.3 Ology Bioservices Inc. Exosome Proteomics Service Introduction
11.20.4 Ology Bioservices Inc. Revenue in Exosome Proteomics Service Business (2018-2023)
11.20.5 Ology Bioservices Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

System Biosciences
HansaBioMed Life Sciences Ltd.
QIAGEN Inc.
Norgen Biotek Corp.
Bio-Techne
AMSBIO LLC
NX Pharmagen
Thermo Fisher Scientific
Sistemic Ltd.
Exosome Diagnostics
Lonza Group Ltd.
Evox Therapeutics Ltd.
Evomic Science LLC
ExoCyte Therapeutics LLC
Optofluidics, Inc.
New England Biolabs
Izon Science Ltd.
Miltenyi Biotec GmbH
Codiak BioSciences
Ology Bioservices Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂